Brian Concannon, President & CEO at HAEMONETICS CORP (HAE), sold 6,569 shares at $35.15 ($231K) on 2015-09-15, disclosed to the SEC on 2015-09-16.
Scheduled sale ($231k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNMD | SELL | 2022-02-04 | $2.9M | — | Filing → |
| CNMD | SELL | 2020-09-14 | $542K | — | Filing → |
| HAE | SELL | 2015-09-02 | $170K | — | Filing → |